Granules India

New approval supports treatment for ADHD and binge eating disorder while addressing critical drug shortages

OAI classification prompts proactive remediation plan; no impact on current manufacturing or product distribution

Company responds to observations and initiates improvements in collaboration with external experts

Granules' climate targets span near-term, long-term, and net-zero goals, aligned with the 1.5°C Pathway

Ovais Sarmad to guide Granules India on climate policy and environmental initiatives

Granules India aims to achieve net zero emissions by 2050, in alignment with the Science Based Targets initiative (SBTi)

It is bioequivalent and therapeutically equivalent to the reference listed drug, Cuvposa Oral Solution, 1 mg/5 mL of Merz…

The current annual US market for Trazodone tablets is approximately $128 million, according to MAT Jun 2024, IQVIA/IMS Health

Colchicine Capsules are indicated for prophylaxis of gout flares in adults

This facility manufactures APIs and formulations of oncology and non-oncology products